Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
Biotechnology Reports (Amsterdam, Netherlands)|October 2, 2025
Solving the light chain mismatch of IgG-like bispecific antibody by utilizing 2A peptide based FaBody platformDong Li, Pengfan Zheng, Xuejing Yao, et al.Journal of Clinical Pharmacology|December 5, 2015
Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus ErythematosusQian Zhao, Xia Chen, Yong Hou, et al.Gynecologic Oncology|March 27, 2025
Therapeutically targeting endometrial cancer in preclinical models by ICAM1 antibody-drug conjugatesHanfei Xie, Lu Sun, Shili Yao, et al.British Journal of Clinical Pharmacology|February 27, 2016
Pharmacokinetics, pharmacodynamics, short term efficacy and safety of RCT-18, a novel BLyS/APRIL fusion protein, in patients with rheumatoid arthritisXia Chen, Qian Zhao, Yong Hou, et al.Life (Basel, Switzerland)|February 25, 2022
A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor ActivityYan Feng, Kun Xie, Yanxin Yin, et al.Clinical Pharmacokinetics|September 3, 2014
Pharmacokinetics, pharmacodynamics, and tolerability of single ascending doses of RCT-18 in Chinese patients with rheumatoid arthritisXia Chen, Yong Hou, Ji Jiang, et al.Plos One|July 1, 2016
Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF TreatmentDong Li, Jiejun Shi, Yanhua Du, et al.Breast Cancer Research and Treatment|August 9, 2015
A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activityXuejing Yao, Jing Jiang, Xin Wang, et al.Journal for Immunotherapy of Cancer|December 2, 2022
Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockadeLijun Xu, Bingyu Li, Chenyu Pi, et al.Stroke|July 13, 2017
Brain Transforming Growth Factor-β Resists Hypertension Via Regulating Microglial ActivationYou Li, Xiao Z Shen, Liang Li, et al.Pageof 12